Related Experiment Video
Updated: Aug 12, 2026

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 14, 2010
[Immunological reactivity of patients with chronic obstructive bronchitis]
Abstract:
The paper is concerned with the results of a study of the immune status in 14 COB patients and 53 patients with COB aggravated by pulmonary emphysema and chronic cor pulmonale. The immunologic reactivity of patients was compared with that of healthy persons and persons suffering from frequent repeated bronchitides (35). Variations in the indices of humoral and cellular immunity and the phagocytic system were noted in the COB patients as compared to the normal values. The most noticeable shifts in the mean values as well as in disorders of interrelationships of immunological indices were noted in the patients with COB aggravated by pulmonary emphysema and chronic cor pulmonale. A decision rule was proposed for determination of imbalance of indices of the patients' immune system.
More Related Videos
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations